What we do

Ten major projects direct research in four key areas of malaria in pregnancy: burden assessment, treatment, prevention and how best to scale up existing strategies and interventions. We work in the following areas of research:

• Treatment
• Prevention Africa
• Prevention Asia and Latin America
• Public Health Impact
• Cross Cutting Activities

Meet the team

Special features on our research team members around the world.

Latest Research

	Intermittent Preventive Therapy for Malaria During Pregnancy Using 2 vs 3 or More Doses of Sulfadoxine-Pyrimethamine and Risk of Low Birth Weight in Africa, systematic review and metanalysis (February 2013)
	Factors Affecting Antenatal Care Attendance: Results from Qualitative Studies in Ghana, Kenya and Malawi (January 2013)
	Maternal Anemia in Pregnancy: Assessing the Effect of Routine Preventive Measures in a Malaria-Endemic Area (January 2013)
	Does Malaria Affect Placental Development? Evidence from In Vitro Models (January 2013)
	Efficacy of Mefloquine Intermittent Preventive Treatment in Pregnancy Against Schistosoma Haematobium Infection In Gabon: A Nested Randomized Controlled Assessor-Blinded Clinical Trial (December 2012)
	Placental Infection With Plasmodium vivax: A Histopathological and Molecular Study (October 2012)
	Malaria and gravidity interact to modify maternal haemoglobin concentrations during pregnancy (October 2012)
	The Malaria in Pregnancy Library: a biblometric review (October 2012)
	Maternal anemia at first antenatal visit: prevalence and risk factors in a malaria-endemic area in Benin (September 2012)

Latest News

	LSTM study by MiP Consortium members leads WHO to update its malaria prevention policy February 2013
	MiP Consortium members and stakeholders present at Challenges in Malaria Research Conference in Basel, Switzerland October 2012
	MiP Consortium members attend Maternal Health Task Force Conference in Istanbul, Turkey June 2012
	New clinician joins crucial MiP Consortium IPTp study in Papua New Guinea May 2012
	MiP Consortium PREGACT initiative undertakes pioneering research into the safety and efficacy of new combination ACT’s May 2012
	MiP Consortium Multicentre Mefloquine treatment study concludes recruitment March 2012